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Abstract
The rapid rollout of Israel’s vaccination program has led to considerable international interest. In this brief
commentary we consider how the criteria for vaccination priority groups differ between Israel and selected
European countries. We argue that following the Israeli approach of using broad criteria for prioritization— i.e.
having fewer groups and a lower age threshold— could have several beneficial effects, including more
manageable logistics and fewer roll out delays, as well as potentially reducing pressure on hospitals. With an
increasing supply of vaccines becoming available rapidly in much of Europe, countries could consider following the
approach of Israel and adopting broader priority criteria going forward.
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Israel has been lauded internationally for its vaccine roll-
out, administering a first dose to over 62% of its popula-
tion as of 8 February while the majority of EU countries
are between 3 and 5% [1]. While it still faces challenges
including high infection rates and vaccine hesitancy,
there are many factors described in the paper by Rosen
et al. that have contributed to Israel’s rapid rollout [2].
Some of these would be challenging if not impossible for
many European countries to replicate, especially at this
stage of the pandemic response. These include the
country’s small size, high population density, a relatively
young population, Israel’s willingness to share data with
manufacturers in return for early vaccine access and
being accustomed to operating on an emergency
preparedness footing (due to security risks). Most im-
portantly, the EU countries, which decided to jointly
purchase vaccines to prevent an ugly competition for
doses, cannot realistically replicate Israel’s speed in pro-
curing enough doses of vaccine to cover their combined
population of 446 million people given how tight the
global market is. Yet the relatively large differences in
the proportions of people who had their first dose ad-
ministered, which ranges from less than 2% in Latvia
and Bulgaria to over 5% in Malta and Denmark [1],
means that some countries have been more effective
than others at rolling out their vaccination programs;
some of this variation could reflect country-specific
prioritization strategies.
McKee & Rajan [3] have highlighted several character-
istics of the Israeli vaccine rollout which countries in the
European region may want to consider in their own
vaccination strategies, including responsibilities for the
delivery of vaccination services and the availability of
corresponding workforce. Here we consider how
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selected country strategies in Europe have compared to
Israel’s vaccine rollout strategy, focusing on the
prioritization of population groups for vaccination. We
draw on Rosen et al. and on information collected for
European countries in the Covid-19 Health System Re-
sponse Monitor (HSRM) [4].
The eligibility criterion used for the first phase of
the rollout varies across countries
Arguably one of the reasons for the rapid vaccine rollout
in Israel is that it has devised very simple vaccination
priority criteria that simultaneously target individuals at
highest risk of death, at highest risk of hospitalization,
and those in most frequent contact with cases. Rosen
et al. report that Israel defined four broad vaccination
groups for its rollout: those age 60 and over; those with
certain pre-existing conditions; nursing home residents;
and front-line health workers. This simple but far-
reaching strategy contrasts with the approaches of some
European countries.
One of the most notable rollout strategy differences is
that some European countries have first focused their at-
tention on frontline health workers and/or care home
residents before the general population above a pre-
defined age, in line with WHO guidance developed for a
context with limited vaccine supply [5]. This approach
recognizes not only that these groups are at a high risk
of exposure to Covid-19, but also that in an over-
stretched health workforce every professional is needed,
especially in ICUs.
For example, in Slovakia health workers, medical stu-
dents, social service home staff, armed forces and some
infrastructure workers are being offered the vaccine in
the first round, while patients over age 65 and the
chronically ill are not eligible until the second round.
Spain is also prioritizing residents and workers in
assisted-living nursing homes, as well as care centres for
highly-disabled people in addition to front line health-
care and social care workers. Only after vaccination of
these groups is completed, other health and social care
workers and non-institutionalised highly dependent
people will be offered the vaccine.
In Latvia health workers treating COVID-19 patients
and professionals working in Emergency Medical
Services (EMS) are in the top priority group. Lithuania
also prioritizes those who work directly with Covid-19
patients. The Dutch Health Council originally recom-
mended a strategy comparable to the Israeli rollout.
However, following lobbying efforts from the hospital
sector, which used the delayed roll out and the prospect
of a third wave to its political advantage, this was chan-
ged to first prioritize hospital and nursing home
personnel over other groups, including older people and
those with pre-existing conditions. Therefore, one key
difference that we note is that in contrast to Israel, some
European countries have not decided to prioritize people
for vaccination based on age.
Among those who do consider age as a priority
criterion, some set high initial age thresholds
There are also differences across countries in the age
threshold used for vaccine prioritization. Among those
countries that prioritize people based on age, many
countries have focused their attention first on the oldest
old, in contrast to Israel’s initial age cut-off of 60 years
and over. Austria, Germany and the United Kingdom
prioritize those 80 years and over before planning to
move incrementally to younger age groups. Germany
prioritizes those 70 years and over in its second phase
and those 60 years and over in its third phase. Estonia
focuses first on those 70 years and over. Portugal in its
first phase is including people age 50 years or older, but
only if they have one of a short list of chronic condi-
tions. Sweden, which initially had an age criterion sim-
pler than the Israeli one, set the age threshold to be all
adults over 18 being vaccinated in the first half of 2021,
reversed course on 4 February and now prioritizes those
above 65.
While there is no definitive rationale for various coun-
tries’ prioritization strategies, it should be noted that al-
though the mortality risk is highest at very old ages and
among care home residents, ICUs in many countries are
currently treating relatively younger patients. In the
Netherlands, for example, the three most represented
age groups (5-year cohorts) in ICUs are between age 60
and 75 [6] This suggests that any approach that ignores
these age groups may do little to alleviate pressures on
health systems, especially if countries decide to re-open
prematurely and infections among younger groups rise.
An increasing supply of vaccines allows for
broader criteria going forward
Naturally many countries have designed their vaccine
rollout strategy based on their own expectations about
their vaccine supply. Scarcity concerns have resulted in
narrow criteria in this early phase of the rollout. Add-
itionally, although it is not decisively demonstrated that
those who are vaccinated stop transmitting Covid-19, in
the event that some degree of transmission is reduced
through vaccination, it could make sense from a societal
perspective to focus on narrowly defined groups who
also are most likely to contribute to community spread.
This being said, there are valuable takeaways from the
simplicity of Israel’s approach to logistics, especially re-
garding the second quarter of 2021, when the scarcity of
the vaccine is expected to become less of a problem in
the EU. A simple set of eligibility criteria, with an age
cut off that is not limited to the oldest old, can be
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beneficial for a number of reasons. These range from
more manageable logistics needed to determine eligibil-
ity to the likelihood of people being aware of when they
are eligible to be vaccinated. The latter is particularly
important for countries that require people to register
for vaccination services, such as Hungary and Greece. It
could also help prevent discord among the population
caused by choices in prioritizations. Furthermore, a
broad strategy may have a more immediate impact on
alleviating pressures on hospitals and ICU units. Lastly,
if countries are resigned to offering the vaccine only to
narrowly defined groups before broadening the criteria,
they may have to contend with significant delays in roll-
out as they face diminishing returns trying to reach all
eligible individuals before proceeding to the next phase.
The pandemic has by necessity created a number of
natural experiments, with countries trying to design the
best possible vaccine rollout based on several determi-
nants, like vaccine supply and a range of country charac-
teristics, as Rosen et al. clearly describe for Israel.
Ongoing comparative research will hopefully provide
more insights into which approach is most effective so
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